← Back to Search

Mobile Technology for Pain Management

N/A

Recruiting

Led By Nirmish Shah

Research Sponsored by Duke University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Currently admitted to the hospital

Any patient 8-80 years old with a past medical history for a chronic disease (such as sickle cell disease), cancer (solid tumor, lymphoma, brain tumor), or currently undergoing bone marrow transplant

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 7 days

Awards & highlights

Study Summary

This trial is testing whether mobile technology can help manage pain in patients with chronic diseases.

Who is the study for?

The TRU-PAIN trial is for hospitalized patients aged 8-80 with chronic diseases like sickle cell, cancer, or those undergoing bone marrow transplant and experiencing pain. It's not for ICU patients or those who can't use a mobile device independently.Check my eligibility

What is being tested?

This study tests if using a SMART app wearable to monitor heart rate, sleep, and movement helps manage pain better than standard care. Patients will be randomly assigned to either the technology-enhanced monitoring or regular treatment after initial feedback.See study design

What are the potential side effects?

Since this trial involves non-invasive mobile technology rather than medication, traditional side effects are not expected. However, there may be discomfort from wearing the device or privacy concerns related to data collection.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am currently in the hospital.

Select...

I am between 8 and 80 years old with a chronic disease, cancer, or am undergoing a bone marrow transplant.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 7 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~7 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

P-Chloroamphetamine

Secondary outcome measures

magnitude of change in pain scores

patient/family satisfaction scores as measured by feasibility survey

time of movement during hospitalization

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: SMART app wearable deviceExperimental Treatment1 Intervention

Patients will be given a wearable such as a Microsoft Band accelerometer to track movement, heart rate, galvanic skin response and sleep, which will be collected in combination with the data from the SMART visual dashboard. Data will be sent to the SMART dashboard as well as stored on the iPad/iPod touch via software from the manufacturer. Participants having a "wearable device" will receive the education intervention (such as haptic prompted texts that state 'try and walk today', 'have you had enough water today', 'make sure to take deep breaths').

Group II: Standard of CareActive Control1 Intervention

Patients will continue with their normal Standard of Care for their condition

0 / 2Eligibility criteria met